Form 8-K - Current report:
SEC Accession No. 0001558370-25-008856
Filing Date
2025-06-25
Accepted
2025-06-25 16:40:16
Documents
12
Period of Report
2025-06-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20250625x8k.htm   iXBRL 8-K 36040
  Complete submission text file 0001558370-25-008856.txt   151540

Data Files

Seq Description Document Type Size
2 EX-101.SCH mxct-20250625.xsd EX-101.SCH 3418
3 EX-101.LAB mxct-20250625_lab.xml EX-101.LAB 16579
4 EX-101.PRE mxct-20250625_pre.xml EX-101.PRE 10718
14 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20250625x8k_htm.xml XML 5019
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 251074116
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)